Epidemiology of hepatitis e virus in China: Results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Jia, Zhiyuan ^a   Yi, Yao ^a   Liu, Jianhua ^b   Cao, Jingyuan ^a   Zhang, Yong ^a   Tian, Ruiguang ^a   Yu, Tao ^a   Wang, Hao ^a   Wang, Xinying ^a   Su, Qiudong ^a   Zhou, Wenting ^a   Cui, Fuqiang ^a   Liang, Xiaofeng ^a   Bi, Shengli ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CHILD; CHINA; CHINESE; CONTROLLED STUDY; ECONOMIC DEVELOPMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HEPATITIS E; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE; VIRUS TRANSMISSION; BLOOD; HEPATITIS E VIRUS; IMMUNOLOGY; INFANT; INFORMATION PROCESSING; ISOLATION AND PURIFICATION; PHYSIOLOGY; YOUNG ADULT;

HEPATITIS E VIRUS;

VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CHINA; DATA COLLECTION; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84910011356     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110837     Document Type: Article

References (44)

1. Emerson SU, Knipe DM, Howley PM, Griffin DE, Lamb RA, et al., eds. (2006) Hepatitis E virus. Fields Virology 5th ed. Philadelphia: Lippincott Williams & Wilkins: 3047-3058.
2. World-Health-Organization (2014) Hepatitis E. Media Centre, World Health Organization 2014. Available: http://www.who.int/mediacentre/factsheets/fs280/en/. Accessed 2012 October 15.
3. Holla RP, Ahmad I, Ahmad Z, Jameel S (2013) Molecular virology of hepatitis E virus. Semin Liver Dis 33: 3-14.
4. Aggarwal R, Jameel S (2011) Hepatitis E. Hepatology 54: 2218-2226.
5. Krumbholz A, Mohn U, Lange J, Motz M, Wenzel JJ, et al. (2012) Prevalence of hepatitis E virus-specific antibodies in humans with occupational exposure to pigs. Med Microbiol Immunol 201: 239-244.
6. El-Tras WF, Tayel AA, El-Kady NN (2013) Seroprevalence of hepatitis E virus in humans and geographically matched food animals in Egypt. Zoonoses Public Health 60: 244-251.
7. Meader E, Thomas D, Salmon R, Sillis M (2010) Seroprevalence of hepatitis E virus in the UK farming population. Zoonoses Public Health 57: 504-509.
8. Li W, Shu X, Pu Y, Bi J, Yang G, et al. (2011) Seroprevalence and molecular detection of hepatitis E virus in Yunnan Province, China. Arch Virol 156: 1989-1995.
9. Liu P, Li L, Wang L, Bu Q, Fu H, et al. (2012) Phylogenetic analysis of 626 hepatitis E virus (HEV) isolates from humans and animals in China (1986-2011) showing genotype diversity and zoonotic transmission. Infect Genet Evol 12: 428-434.
10. Li K, Zhuang H, Zhu W (2002) Partial nucleotide sequencing of hepatitis E viruses detected in sera of patients with hepatitis E from 14 cities in China. Chin Med J (Engl) 115: 1058-1063.
11. Yu Y, Sun J, Liu M, Xia L, Zhao C, et al. (2009) Seroepidemiology and genetic characterization of hepatitis E virus in the northeast of China. Infect Genet Evol 9: 554-561.
12. Geng JB, Wang MR, Wang L, Wang J, Yang ZG, et al. (2012) Genetic characteristics and pathogenicity of human hepatitis E virus in Nanjing, China. World J Gastroenterol 18: 965-970.
13. Chiu DM, Chan MC, Yeung AC, Ngai KL, Chan PK (2013) Seroprevalence of hepatitis E virus in Hong Kong, 2008-2009. J Med Virol 85: 459-461.
14. Liang X, Bi S, Yang W, Wang L, Cui G, et al. (2009) Epidemiological serosurvey of hepatitis B in China - declining HBV prevalence due to hepatitis B vaccination. Vaccine 27: 6550-6557.
15. Verhoef L, Koopmans M, Duizer E, Bakker J, Reimerink J, et al. (2012) Seroprevalence of hepatitis E antibodies and risk profile of HEV seropositivity in The Netherlands, 2006-2007. Epidemiol Infect 140: 1838-1847.
16. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, et al. (2012) Hepatitis E. Lancet 379: 2477-2488.
17. Takahashi M, Tamura K, Hoshino Y, Nagashima S, Yazaki Y, et al. (2010) A nationwide survey of hepatitis E virus infection in the general population of Japan. J Med Virol 82: 271-281.
18. Scotto G, Martinelli D, Giammario A, Prato R, Fazio V (2013) Prevalence of antibodies to hepatitis E virus in immigrants: a seroepidemiological survey in the district of Foggia (Apulia-southern Italy). J Med Virol 85: 261-265.
19. Fogeda M, Avellon A, Echevarria JM (2012) Prevalence of specific antibody to hepatitis E virus in the general population of the community of Madrid, Spain. J Med Virol 84: 71-74.
20. Romano L, Paladini S, Tagliacarne C, Canuti M, Bianchi S, et al. (2011) Hepatitis E in Italy: a long-term prospective study. J Hepatol 54: 34-40.
21. Faramawi MF, Johnson E, Chen S, Pannala PR (2011) The incidence of hepatitis E virus infection in the general population of the USA. Epidemiol Infect 139: 1145-1150.
22. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, et al. (2009) Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 200: 48-56.
23. Kmush B, Wierzba T, Krain L, Nelson K, Labrique AB (2013) Epidemiology of hepatitis E in low- and middle-income countries of Asia and Africa. Semin Liver Dis 33: 15-29.
24. Majumdar M, Singh MP, Pujhari SK, Bhatia D, Chawla Y, et al. (2013) Hepatitis E virus antigen detection as an early diagnostic marker: report from India. J Med Virol 85: 823-827.
25. Villalba MC, Guan M, Perez A, Corredor MB, Frometa SS, et al. (2010) Seroprevalence of antibodies to hepatitis E virus in two large communities in Havana, Cuba. Trans R Soc Trop Med Hyg 104: 772-776.
26. Vivek R, Chandy GM, Brown DW, Kang G (2010) Seroprevalence of IgG antibodies to hepatitis E in urban and rural southern India. Trans R Soc Trop Med Hyg 104: 307-308.
27. Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, et al. (2009) Population seroprevalence of hepatitis E virus antibodies in rural Bangladesh. Am J Trop Med Hyg 81: 875-881.
28. Mohebbi SR, Rostami Nejad M, Tahaei SM, Pourhoseingholi MA, Habibi M, et al. (2012) Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg 106: 528-531.
29. Bawazir AA, Hart CA, Sallam TA, Parry CM, Beeching NJ, et al. (2010) Seroepidemiology of hepatitis A and hepatitis E viruses in Aden, Yemen. Trans R Soc Trop Med Hyg 104: 801-805.
30. Zhuang H, Cao XY, Liu CB, Wang GM (1991) Epidemiology of hepatitis E in China. Gastroenterol Jpn 26 Suppl 3: 135-138.
31. Zhang S, Wang J, Yuan Q, Ge S, Zhang J, et al. (2011) Clinical characteristics and risk factors of sporadic Hepatitis E in central China. Virol J 8: 152.
32. Zhicheng Dai GQea (1997) Viral hepatitis in China. : Scientific and Technical Documentation Press.1997; 19831994-
33. Xue-feng ZJ, She-lan L, Hua T, Ke X, Fan-yue M, et al. (2008) Study on hepatitis E virus infection in rural general population in Jiangsu province. Acta Universitatis Medcinealis Nanjing(Natural Science) 3: 360-363.
34. Cai JL, Xu J, Liang J, Li Z, Zhang C, et al. (2010) Epidemiological Characteristics of viral hepatitis E in Guangzhou. Journal of tropical Medicine Vol.10 No. 1 Jan: 90-97.
35. Taniguchi M, Kim SR, Mishiro S, Takahashi K, Shin MH, et al. (2009) Epidemiology of hepatitis E in Northeastern China, South Korea and Japan. J Infect 58: 232-237.
36. Li RC, Ge SX, Li YP, Zheng YJ, Nong Y, et al. (2006) Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China. Emerg Infect Dis 12: 1682-1688.
37. Yan J, Kanda T, Wu S, Imazeki F, Yokosuka O (2012) Hepatitis A, B, C and E virus markers in Chinese residing in Tokyo, Japan. Hepatol Res 42: 974-981.
38. Aggarwal R, Naik S (2009) Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol 24: 1484-1493.
39. Lu J, Zhou Y, Lin X, Jiang Y, Tian R, et al. (2009) General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: a cross-sectional study in 2007. PLoS One 4: e8467.
40. Yao GB (1989) [A brief account of the 1988 seminar in Shanghai on viral hepatitis A]. Zhonghua Yi Xue Za Zhi 69: 113-114.
41. Xu ZY, Li ZH, Wang JX, Xiao ZP, Dong DX (1992) Ecology and prevention of a shellfish-associated hepatitis A epidemic in Shanghai, China. Vaccine 10 Suppl 1: S67-68.
42. Aggarwal R, Jameel S (2008) Hepatitis E vaccine. Hepatol Int 2: 308-315.
43. Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. (2013) Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Clin Microbiol Infect.
44. Wu T, Li SW, Zhang J, Ng MH, Xia NS, et al. (2012) Hepatitis E vaccine development: a 14 year odyssey. Hum Vaccin Immunother 8: 823-827.